SSMR enters September with an unusual split: a freshly covered stock with unanimous bullish analyst backing, yet one that has just surrendered nearly 10% in a single week after a standout August.
The Street's enthusiasm is real and recent. Morgan Stanley initiated with an Overweight rating and a $23 target in late June, followed by Scotiabank lifting its target to $21 and reiterating Sector Outperform in mid-July, and Canaccord Genuity adding a Speculative Buy at $20 on August 18. All three buy-rated analysts carry targets well above the current price of $16.79 — the consensus mean is $19.33, implying roughly 15% implied upside from here. That gap has widened sharply in just a week as the stock fell from above $18. The analyst community has been uniformly constructive since the IPO coverage wave in late June, though notably none of those initiations have yet been tested by a full earnings cycle.
The lending market tells a quiet story for now. Availability is extraordinarily loose — there are roughly 24 shares available to borrow for every one currently lent out, a level that signals no meaningful pressure on short sellers either to cover or to find new borrows. Cost to borrow has also collapsed, nearly halving over the past month to just 1.83%, the lowest level in the 30-day window. Short interest has edged up about 16% over the week in share terms, reaching roughly 687,000 shares, but without float data the precise percentage is unavailable. What is clear is that the absolute short position remains small relative to available borrow supply, and the ORTEX short score of 34.6 — steady over the past two weeks — gives no signal of an aggressive or accelerating bear thesis. Positioning here looks cautious at best, not crowded.
The ownership picture is the most distinctive feature of this name. Thomas Scott Kaplan, the chairman, holds a disclosed 62.9% of the class per a Schedule 13G filed on August 7. Ospraie Real Assets Fund LP holds a further 17.3%, per its own 13G filed August 10. Together, those two holders account for over 80% of the company — an extraordinarily concentrated register. Both filers are on passive 13G schedules rather than activist 13D filings, meaning no activist agenda is formally disclosed. That said, the float available to outside investors is thin by any measure. The June 5 insider activity was mixed: the CEO, general counsel, and several directors each bought shares at $13.50 on the same day, while Kaplan and Ospraie both sold material positions at the same price. The net 90-day insider figure is positive at roughly 1.2 million shares, though the simultaneous buy-and-sell pattern on the IPO date likely reflects the mechanics of the listing rather than a conventional buying signal.
Earnings history adds one data point worth noting. The most recent print on August 13 produced a one-day drop of just over 7%, though the stock recovered to near flat by the five-day mark. The prior event on August 10 saw a 5.8% gain. The pattern is thin — only a handful of events are in the record — but both reactions reversed within the week, suggesting the market is still calibrating fair value on a name with limited trading history. The next event is scheduled for November 12.
With the stock now back below every analyst's price target and the borrow market entirely relaxed, the question heading into autumn is whether the week's pullback from the August peak attracts fresh buyers or simply reflects the end of the post-listing momentum trade.
See the live data behind this article on ORTEX.
Open SSMR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
